Enhancing Keratinized Mucosa around dental implants:A comparotive study of linear gingival graft with xenogenous collagen matrix and concentrated growth factors

Comparative evaluation of the effect of linear gingival graft along with xenogenous collagen graft and concentrated growth factors matrix in enhancing the dimensions of Keratinized mucosa around dental implants - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106063

Enrollment

Registered

2026-03-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified

Interventions

Intervention1: group-1(Xenogenous collagenous matrix): using linear srtip gingival graft with xenogenous collagenous matrix followed by placing Neodent implants Intervention2: concentrated growth fact

Eligibility

Inclusion criteria

Inclusion criteria: Presence of insufficient keratinized mucosa at implant sites Healed implant sites indicated for soft-tissue augmentation Patients aged 25-65 years Systemically healthy individuals Patients willing to participate and comply with follow-up visits

Exclusion criteria

Exclusion criteria: Patients with uncontrolled systemic diseases (e.g., uncontrolled diabetes, immunocompromised conditions) Smokers or tobacco users Pregnant or lactating women Patients with active periodontal or peri-implant infection History of radiation therapy in the head and neck region Poor oral hygiene or non-compliant patients Patients on medications affecting wound healing (e.g., long-term steroids, bisphosphonates)

Design outcomes

Primary

Measure	Time frame
1.To evaluate the gain in width of keratinized mucosa at implant sites following linear strip gingival graft in combination with a xenogeneic collagen matrix (XCM)or concentrated growth factors (CGF) Timepoint: 1st,4th 12th week	—

Secondary

Measure	Time frame
1.To compare the patient reported outcomes assessed using visual analog scale for A.patient satisfaction B.Morbidity/discomfort (pain) C.Patient willingness to undergo the same procedure again, if necessary 2.To assess wound healing during 1st,4th and 12th weekTimepoint: Assessing wound healing around 1st,4th,12th week	—

Countries

India

Contacts

Public ContactDr V Santhosh Devanathan

SRM Dental College CHENNAI

drsandev@gmail.com8148877084

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026